Stocks and securities in focus
| Security | Change (%) | 1w | 1m | 1y | YTD | 3y | 5y ▼ |
|---|---|---|---|---|---|---|---|
| Catalyst Pharmaceutical Partners Inc | 0.380% | 3.929% | 0.000% | -8.346% | -6.371% | 274.614% | 546.667% |
| Boston Scientific | -0.720% | 2.222% | 8.661% | 42.474% | 34.137% | 94.695% | 109.854% |
| Stryker Corp. | -0.260% | 1.051% | -4.796% | 18.895% | 14.047% | 46.944% | 85.272% |
| Merit Medical Systems | -1.360% | 4.255% | 10.526% | -4.545% | 8.088% | 38.679% | 47.650% |
| Novavax Inc. | 97.310% | -4.482% | 2.778% | -51.686% | -5.969% | -97.094% | -35.803% |
| Fresenius SE & Co. KGaA | 1.890% | -0.460% | 10.669% | 1.664% | -0.496% | -32.306% | -44.676% |
| Fresenius Medical Care AG & Co KGaA ADR | 3.260% | -5.641% | 5.747% | -13.208% | -1.604% | -42.857% | -49.451% |
| Salarius Pharmaceuticals Inc. | 2.480% | -12.174% | -6.047% | -77.430% | -27.207% | -98.343% | -99.993% |
| Fate Therapeutics Inc. | 9.850% | -5.579% | -41.534% | -26.474% | 1.378% | -94.276% | - |
| Cytomx Therapeutics Inc | -15.850% | -47.768% | 14.950% | 38.953% | 55.874% | -67.858% | - |
| MacroGenics Inc. | -77.710% | -4.014% | -18.285% | 106.515% | 51.444% | -50.128% | - |
| Evolus Inc | -1.650% | 2.542% | 0.000% | 47.561% | 33.702% | 64.626% | - |
| Newron Pharmaceut. | 0.580% | - | - | - | - | - | - |
| BeiGene Ltd ADR | -5.100% | 3.974% | 10.563% | -29.911% | -4.848% | -38.672% | - |
| X4 Pharmaceuticals, Inc. | -2.410% | -5.450% | -15.106% | -28.237% | 27.885% | - | - |
| Ardelyx Inc. | -3.860% | 19.664% | 14.204% | 98.895% | 30.761% | 36.180% | - |
| Inogen Inc. | 2.610% | 22.901% | 12.587% | -20.297% | 51.887% | -85.364% | - |